Centre for Medicine Use and Safety
Researchers from CMUS have been elected to the Australian Deprescribing Network (ADeN) Executive Committee, marking another key achievement for the Centre.
Monash University researchers have conducted a review into the prevalence of depression and anxiety of people with cystic fibrosis, a life-limiting genetic disease associated with high levels of psychological burden.
Her PhD thesis is entitled "Mechanism-based pharmacokinetic/pharmacodynamic modelling and meta-analysis to address challenges in antibiotic therapy for specific patient populations".
A new Monash randomised controlled trial called ‘TERRACOTTA’ will set out to address deficiencies in Australia’s primary care relating to COPD management.
Development of the Guidelines were led by Centre for Medicine Use and Safety, with funding from the National Health and Medical Research Council Dementia Centre for Research Collaboration in response to recommendations from the recent Royal
Researchers from the Centre for Medicine Use and Safety have been awarded the prestigious 2022 American Medical Directors' Association JAMDA Morley Award for their paper Medication Management in Frail Older People: Consensus Principles for Clinical
Monash University PhD candidate, Shin Liau, has been awarded the prestigious Inaugural Australian Association of Gerontology (AAG) Helen Barrie National Special Prize for leading an international collaboration in the development of consensus
New research from Monash University’s Centre for Medicine Use and Safety (CMUS) has found that nearly one quarter of Australians who initiate common diabetes medications switch or receive additional medications during the first year.
An international study led by Monash University’s Centre for Medicine Use and Safety has investigated the effectiveness of health service interventions to improve analgesic use and appropriateness in residential aged care facilities.